Tirzepatide (CAS 2023788-19-2) is a GMP-compliant, high-purity dual GIP/GLP-1 receptor agonist peptide API. FDA-approved for type 2 diabetes glycemic control and chronic weight management, it delivers robust glucose-lowering and sustained weight loss efficacy. It fully meets ICH, USP and EP standards for injectable pharmaceutical R&D and commercial manufacturing.
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
2023788-19-2Tirzepatide (CAS 2023788-19-2) is a GMP-compliant, high-purity dual GIP/GLP-1 receptor agonist peptide API. FDA-approved for type 2 diabetes glycemic control and chronic weight management, it delivers robust glucose-lowering and sustained weight loss efficacy. It fully meets ICH, USP and EP standards for injectable pharmaceutical R&D and commercial manufacturing.
Our hours
Monday to Friday
(8:30-17:30)